Yukon Medical

What Yukon Medical does

Yukon Medical is a privately held medical device manufacturer headquartered in Durham, North Carolina, that designs and produces closed system transfer devices (CSTDs) and vial access devices for hazardous injectable medication preparation and administration. The company was spun out from Gilero in 2011 by Todd Korogi, who had previously founded Gilero in 2002 as a medical device product development services firm. Yukon Medical's core technology platform is built around needleless, membrane-to-membrane sealed interfaces using familiar luer-lock connections, intended to reduce hazardous drug exposure and needlestick injuries while minimizing workflow disruption relative to legacy needled CSTDs.

The product portfolio is organized into two families. The Arisure CSTD platform comprises three integrated components — the Closed Male Luer, Closed Vial Adapter, and Dry Spike — that together enable closed transfer from vial access through IV bag transfer and administration. The Vialok family provides needle-free vial access devices available in vented (0.2 micron filter) and non-vented configurations with a dual-lumen spike designed to minimize residual medication. A specialized AT-Adapt component integrates with Aseptic Technologies' 20 mm AT-Closed Vial to serve cell and gene therapy workflows. The company has secured US 510(k) clearances, Canadian device licensing, and EU CE Mark certification, with active registration in 21 additional countries, and maintains ISO 13485, 21 CFR Part 820, and 21 CFR Part 11 compliance.

Yukon Medical operates a B2B enterprise field sales model, reaching healthcare clinicians and care teams as its primary segment, with secondary penetration into pharmaceutical manufacturers and cell and gene therapy companies. Revenue is generated through hardware sales of disposable medical devices distributed via direct enterprise sales (phone and email inquiries), likely through established medical device supply chains. No public pricing, revenue figures, or distribution partner agreements are disclosed. The company has no disclosed institutional funding, no parent company, and no subsidiaries, operating as an independent LLC with a small employee base.

Name

Yukon Medical

Legal name

Yukon Medical LLC

Website

https://yukonmedical.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Yukon Medical designs and manufactures needleless closed system transfer devices and vial access devices for hazardous medication preparation and delivery. The company serves healthcare institutions, pharmacies, pharmaceutical manufacturers, and cell and gene therapy companies.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Prefilled Syringes & Safety Syringes (HLAHAIAA)

Keywords

• Closed system transfer devices
• Hazardous drug handling
• Vial access devices
• Needleless medical devices
• Chemotherapy preparation systems

Headquarters

HQ city

Durham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Yukon Medical generates revenue through the sale of medical devices including the Arisure Closed System Transfer Device platform and Vialok Vial Access Devices. These are physical medical devices sold to healthcare institutions, pharmacies, and pharmaceutical companies for use in medication preparation and delivery workflows.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Yukon Medical designs and manufactures needleless closed system transfer devices (CSTDs) and vial access devices for hazardous drug preparation and administration. Its two product families — the Arisure CSTD platform (Closed Male Luer, Closed Vial Adapter, Dry Spike) and Vialok Vial Access Devices — use membrane-to-membrane sealed interfaces and luer-lock connections to enable safer handling of hazardous injectable medications in clinical and pharmaceutical settings.

Product overview

Yukon Medical designs and manufactures advanced systems for injectable medication preparation and delivery, organized around two main product families: the Arisure closed system transfer device platform and the Vialok vial access device family. The Arisure system is a needleless, membrane-to-membrane CSTD platform for hazardous drug handling, consisting of three interconnected components—the Closed Vial Adapter, Closed Male Luer, and Dry Spike—that work together to enable closed transfer from vial access through bag transfer and administration. The Vialok family provides secure vial access devices for medication preparation, available in vented (with 0.2 micron filter) and non-vented configurations, with an additional AT-Adapt component for integration with Aseptic Technologies' AT-Closed Vials. Both product families share a common design philosophy emphasizing simplicity, safety, and familiar luer-lock connections to minimize workflow disruption.

Differentiator

Problem solved

Functional benefit

Brands

• Arisure: Closed System Transfer Device (CSTD) platform for needleless hazardous drug preparation and administration, including Closed Male Luer, Closed Vial Adapter, and Dry Spike components.
• Vialok

Products and services

• Arisure Closed System Transfer Device A needleless, membrane-to-membrane closed system transfer device platform for hazardous drug preparation and administration, featuring luer-lock connections to enable simpler, safer medication handling with fewer workflow disruptions than traditional CSTDs.
• Arisure Closed Male Luer A needle-free connector that serves as the central connection point of the Arisure system, combining a luer-lock interface with a membrane-to-membrane seal for dry, fully closed disconnects during hazardous medication preparation and administration.
• Arisure Closed Vial Adapter A vial access device that provides a secure, membrane-to-membrane interface to maintain a fully closed pathway during vial access for hazardous medication preparation, featuring a non-coring spike and luer-lock connection.
• Arisure Dry Spike A closed-system IV bag access device for transferring hazardous injectable medications while maintaining a closed pathway, featuring a double-seal design and high flow rate for controlled fluid transfer.
• Vialok Vial Access Device Secure vial access devices for needle-free medication preparation in clinical and pharmacy settings, available in vented (0.2 micron filter) and non-vented configurations with a dual-lumen spike design to minimize residual medication.
• AT-Adapt (ADA010 Vial Adapter) A specialized vial adapter designed to integrate with Aseptic Technologies' 20 mm AT-Closed Vial, supporting closed-system processing and reducing contamination risk in compatible drug delivery systems.

Quantifiable outcome

• Reduced medication waste through dual-lumen spike design
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Equashield: Equashield is a pure-play CSTD manufacturer whose flagship Equashield system directly competes with Yukon Medical's Arisure platform for hazardous drug handling in hospitals and compounding pharmacies. Both companies target the same USP <800>-driven clinical workflow with closed-system vial, syringe, and IV-bag components.

Broad incumbents

• ICU Medical: ICU Medical offers the ChemoClave and Texium CSTD lines as part of a broad medical-connectivity and IV-therapy portfolio. Yukon Medical competes with ICU Medical's hazardous-drug handling devices across hospitals and infusion centers while ICU's broader offering creates bundling pressure.
• Becton Dickinson (BD): BD owns the PhaSeal CSTD, the legacy market-leading closed-system transfer device, alongside medication delivery, injection, and infusion franchises. PhaSeal is Yukon's most entrenched competitor and benefits from BD's clinical evidence, sales coverage, and contract footprint.
• West Pharmaceutical Services: West supplies elastomeric components, stoppers, seals, and syringe/cartridge parts to injectable drug manufacturers. Yukon Medical's AT-Adapt integration with Aseptic Technologies' AT-Closed Vials positions it within the same pharma-packaging component ecosystem.
• B. Braun: B. Braun is a global IV therapy, infusion, and injection device manufacturer with oncology and hazardous-drug handling offerings. Its scope of IV administration sets, transfer sets, and compounding solutions overlaps Yukon Medical's hazardous-drug delivery and vial-access workflows.
• Teleflex: Teleflex manufactures a broad portfolio of drug delivery and anesthesia devices that intersect with vial access, transfer, and IV administration. Yukon's Vialok and Arisure products compete in adjacent product categories served by Teleflex's hospital channel.
• Fresenius Kabi: Fresenius Kabi provides IV drugs, infusion solutions, and medical devices for oncology and compounding pharmacies. Its closed-system accessories and pharmacy compounding portfolio provide direct competitive overlap with Yukon Medical's pharma and clinician segments.

Emerging players

• Corvida Medical: Corvida Medical is a smaller, focused CSTD developer competing in the same hazardous-drug preparation market as Yukon Medical. Its Halo closed system, like Arisure, targets workflow-friendly closed transfer; both firms compete for share against incumbents.
• Simplivia Healthcare: Simplivia manufactures Tevadaptor CSTDs marketed outside the US to pharmacy and oncology compounding customers. Yukon Medical's international expansion plan overlaps directly with Simplivia's European and emerging-market footprint.

Regional players

• Terumo: Terumo manufactures injection, infusion, and drug-delivery devices primarily serving Asian and European healthcare markets. Its prefilled syringe and safety-engineered device lines overlap Yukon's safety-focused drug-delivery positioning, though its geographic emphasis differs.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/yukon-medical-llc
• Xx.com/YukonMedical

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yukon Medical